Medite Cancer Diagnostics Inc (MDIT)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 22, 16:00
Medite Cancer Diagnostics Cash from Investing (TTM): -0.106M for Sept. 30, 2018
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2018 | -0.106M |
| June 30, 2018 | -0.111M |
| March 31, 2018 | -0.12M |
| December 31, 2017 | -0.134M |
| September 30, 2017 | -0.161M |
| June 30, 2017 | -0.035M |
| March 31, 2017 | -0.037M |
| December 31, 2016 | -0.115M |
| September 30, 2016 | -0.178M |
| June 30, 2016 | -0.455M |
| March 31, 2016 | -0.316M |
| December 31, 2015 | -0.354M |
| September 30, 2015 | -0.245M |
| June 30, 2015 | -0.20M |
| March 31, 2015 | -0.436M |
| December 31, 2014 | -0.462M |
| September 30, 2014 | -0.206M |
| June 30, 2014 | -0.213M |
| March 31, 2014 | -0.253M |
| December 31, 2013 | -0.095M |
| September 30, 2013 | -0.209M |
| June 30, 2013 | -0.08M |
| March 31, 2013 | 0.07M |
| December 31, 2012 | 0.07M |
| September 30, 2012 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | -0.016M |
| March 31, 2011 | -0.036M |
| December 31, 2010 | -0.036M |
| September 30, 2010 | -0.057M |
| June 30, 2010 | -0.058M |
| March 31, 2010 | -0.054M |
| December 31, 2009 | -0.071M |
| September 30, 2009 | -0.265M |
| June 30, 2009 | -0.481M |
| March 31, 2009 | -1.069M |
| December 31, 2008 | -1.683M |
| September 30, 2008 | -1.543M |
| June 30, 2008 | -1.328M |
| March 31, 2008 | -0.763M |
| December 31, 2007 | -0.324M |
| September 30, 2007 | -0.448M |
| June 30, 2007 | -0.449M |
| March 31, 2007 | -0.41M |
| December 31, 2006 | -0.219M |
| September 30, 2006 | -0.02M |
| June 30, 2006 | -0.018M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.106M
Minimum
Sep 2018
-0.106M
Maximum
Sep 2018
-0.106M
Average
-0.106M
Median
Sep 2018
Cash from Investing (TTM) Benchmarks
| Urologix Inc | -0.061M |
| Caliber Imaging & Diagnostics Inc | -0.1838M |
| Newcardio Inc | -- |
| SheerVision Inc | -- |
| Sunridge International Inc | -- |